Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Novartis Europharm Limited, against the decision of the State Institute for Drug Control from 27. 11. 2019, under the no.: SUKLS203070/2016:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 31. 12. 2019, under the no.: SUKLS37719/2014:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 29. 3. 2021, under the no.: SUKLS231546/2016:

• the decision is partially reversed and the proceedings are terminated  
• the appeal is dismissed and the decision under appeal is partially upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant RECORDATI IRELAND Ltd, Sandoz s.r.o., Sandoz GmbH and LEK PHARMACEUTICALS D.D. against the decision of the State Institute for Drug Control from 29. 5. 2020, under the no.: SUKLS31854/2020:

• the decision is partially reversed and the proceedings are terminated  
• the appeal is dismissed and the decision under appeal is partially upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Novartis s.r.o., against the decision of the State Institute for Drug Control from 17. 9. 2021, under the no.: SUKLS5338/2021:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant EGIS Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 30. 3. 2020, under the no.: SUKLS110723/2015:

• the decision is partially reversed and the proceedings are terminated  
• the appeal is dismissed and the decision under appeal is partially upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Boehringer Ingelheim International GmbH, Merck Sharp & Dohme B.V. and Novartis Europharm Limited, against the decision of the State Institute for Drug Control from 17. 4. 2020, under the no. SUKLS151561/2014:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Cipla Europe NV, against the decision of the State Institute for Drug Control from 7. 10. 2021, under the no.: SUKLS196911/2021:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.